Lyra Therapeutics (LYRA) EPS (Diluted) (2021 - 2025)
Lyra Therapeutics (LYRA) EPS (Diluted) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.31 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.23 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.33 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.05 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.19 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.15 |
| 10 | Lyra Therapeutics | 70,995.28 | 70,995.28 | - | -0.56 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.56 |
| Sep 30, 2025 | -3.38 |
| Jun 30, 2025 | -5.51 |
| Mar 31, 2025 | -6.50 |
| Dec 31, 2024 | 6.66 |
| Sep 30, 2024 | -9.07 |
| Jun 30, 2024 | -36.76 |
| Mar 31, 2024 | -17.54 |
| Dec 31, 2023 | -15.22 |
| Sep 30, 2023 | -13.74 |
| Jun 30, 2023 | -17.88 |
| Mar 31, 2023 | -22.07 |
| Dec 31, 2022 | -23.52 |
| Sep 30, 2022 | -20.05 |
| Jun 30, 2022 | -21.16 |
| Mar 31, 2022 | -45.78 |
| Dec 31, 2021 | -52.71 |
| Sep 30, 2021 | -56.90 |
| Jun 30, 2021 | -53.95 |
| Mar 31, 2021 | -51.53 |